Reimagining the Water Bottle: Jabil Packaging Solutions Launches VITTEL® Hybrid Bottle
9.6.2021 15:47:00 EEST | Business Wire | Press release
Jabil Packaging Solutions, a division of Jabil Inc. (NYSE: JBL), today launched its latest packaging prototype: the Eco.bottle® product platform for VITTEL®, a leading mineral water brand in Europe from the water division of Nestlé. Designed for scalability by a team including Ecologic Brands, acquired by Jabil earlier this year, the VITTEL® hybrid bottle leverages paper and plastic components, resulting in a plastic reduction of more than 50 percent compared to VITTEL®’s current 1-liter bottle. Moreover, this bottle features a patent-pending, first-of-its-kind tear strip, enabling easy separation of the paper and plastic components for an efficient, consumer-friendly recycling experience. This breakthrough innovation is comprised of 100 percent recycled paper and plastic materials, creating a circular system from readily available, high-volume waste streams. Consumer testing in Europe will begin in June and the bottle will be showcased to the media during the upcoming Tour de France, taking place June 26, 2021 through July 18, 2021.
“True innovation in sustainable packaging requires a holistic view of the product that goes beyond aesthetics, material selection and design features,” said Julie Corbett, senior business unit director of Jabil and founder of Ecologic Brands. “Our goal is to innovate around the entire life cycle of the bottle, not only to decrease the use of plastic. That’s why the Eco.bottle® product platform is engineered to drive plastic reduction, improve carbon footprint and optimize the consumer recycling experience.”
Constructed of 80 percent paper and only 20 percent recycled plastic (cap included), the VITTEL® hybrid bottle’s two-shell system, enabled by interlocking paper tabs, allows for nesting during transit and warehousing. This eliminates extra space in the supply chain and has the potential to lessen the amount of trucks needed for delivery by 50-60 percent.
The VITTEL® hybrid bottle project began in 2020; in less than one year, VITTEL® and Jabil have successfully delivered one of the world’s first hybrid water bottles. VITTEL’s deep knowledge of mineral water bottling helped achieve the thinnest 1-liter plastic liner in the market today, which uses just 9.2g of recycled plastic. Jabil’s conversion technology and expertise enabled the fabrication of an elegant and functional outer shell made of certified Forest Stewardship Council reclaimed and recycled material.
“It’s no longer enough for CPG companies to say they’ve reduced their waste. They now also need compelling solutions for repurposing that waste,” said Jason Paladino, senior vice president of Jabil and CEO of Jabil Packaging Solutions. “Jabil’s Box-to-Bottle® manufacturing platform allows us to take our customers' waste and incorporate it into our manufacturing process within our facilities in Manteca, California and Tortosa, Spain. This fully accountable and traceable manufacturing platform provides forward-thinking brands like VITTEL® with unparalleled visibility into the circularity of their products.”
“Thanks to Jabil’s innovative Eco.bottle® product platform, the VITTEL® hybrid bottle is the result of a journey launched several years ago to explore options for drastically reducing the proportion of plastic in our packaging,” said Laure Goutagneux, VITTEL® marketing director. “We are thrilled with the results of our collaboration, including a plastic reduction of 50 percent when compared to our current lightweight bottles.”
About Jabil:
Jabil (NYSE: JBL) is a manufacturing solutions provider with over 260,000 employees across 100 locations in 30 countries. The world's leading brands rely on Jabil's unmatched breadth and depth of end-market experience, technical and design capabilities, manufacturing know-how, supply chain insights and global product management expertise. Driven by a common purpose, Jabil and its people are committed to making a positive impact on their local community and the environment. Visit www.jabil.com to learn more.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210609005197/en/
Contact information
Media Contact
Michelle Smith
VP Communications & Brand Strategy, Jabil
(813) 415-1116
michelle_smith@jabil.com
Investor Contact
Adam Berry
VP Investor Relations, Jabil
(727) 803-5772
adam_berry@jabil.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OdysseyRe Announces New Co-Chief Underwriting Officers for EMEA18.5.2026 10:00:00 EEST | Press release
Odyssey Reinsurance Company (OdysseyRe) today announced the appointments of Tegwen Gromellon and Anne-Claire Serres as co-chief underwriting officers of its EMEA division, effective July 1. They succeed longtime Chief Underwriting Officer, Gaël Le Païh, who is retiring later this year following 36 years with the Company. Based in Paris, Serres joined OdysseyRe in 2018 as the market director for France and will lead the division’s business across France, Africa and the Middle East. Gromellon, who joined OdysseyRe in 2004, has served as market director for Germany, Austria, Benelux and Switzerland since 2019. He will take the lead for the rest of Europe, including the relationship with the Company’s representative office in Stockholm for the Nordic markets and across Turkey. “We are delighted to appoint both Tegwen and Anne-Claire to these important leadership positions,” said Isabelle Dubots-Lafitte, chief executive officer of EMEA for OdysseyRe. “These appointments recognize their sign
Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy18.5.2026 10:00:00 EEST | Press release
Prokarium, a clinical-stage biopharmaceutical company pioneering bacterial immunotherapies for the treatment of solid tumours, today announced safety and antitumour efficacy results from an interim review of the ongoing Phase 1/1b PARADIGM-1 trial of ZH9 in non-muscle invasive bladder cancer (NMIBC) patients. These data were shared via an oral podium presentation at the American Urology Association (AUA26) Annual Meeting. Prokarium CMO, Dr Josefin-Beate Holz said “These data demonstrate ZH9 as a universally applicable treatment for patients. As the treatment is very well tolerated and is showing impactful outcomes for early and BCG-non-responsive patients alike, it opens up the potential for ZH9 to be a transformative bladder saving treatment.” "There is a clear and urgent need to move beyond BCG. The current treatment burden—requiring up to 18 catheterisations in the first year— detrimentally impacts real-world compliance and patient outcomes," said Ibs Mahmood, CEO of Prokarium. "Pat
Arboris Capital Selects ROYC to Expand Private Markets Capabilities on CapGain Platform18.5.2026 10:00:00 EEST | Press release
Arboris Capital Limited (“Arboris”), a DIFC-based firm arranging alternative investments, authorised by the Dubai Financial Services Authority (DFSA), today announced that it has selected ROYC AB (“ROYC”), a private markets technology and infrastructure provider, to support the continued development of its private markets offering through its platform, CapGain. In its ongoing efforts to expand its private markets capabilities across the Middle East, Arboris has undertaken a strategic review of how to further scale its offering while maintaining the integrity of its existing platform. As a result, Arboris has chosen to integrate ROYC’s fund access, sourcing, and structuring capabilities into CapGain, complementing its existing infrastructure. CapGain is Arboris’s proprietary investment platform, purpose-built to facilitate access between international private market opportunities and Professional Investors in the region. CapGain provides fully digital investor onboarding and KYC, a secu
LogicMonitor and Deutsche Telekom Expand Partnership Across Europe18.5.2026 10:00:00 EEST | Press release
LogicMonitor®, the AI-first platform for Autonomous IT, today announced the expanded availability of its platform within Deutsche Telekom’s managed services portfolio across selected European markets, including DACH, Benelux, and the Nordics. The expansion builds on operational use of LogicMonitor in the United Kingdom since 2023, where it has supported Deutsche Telekom’s service teams in improving visibility across network, cloud, and hybrid infrastructure environments. Experience gained from these deployments is now informing broader service enablement across additional European markets. As enterprise IT environments grow more complex, organisations require more than visibility—they need predictive resilience. Through defined use cases, LogicMonitor complements Deutsche Telekom’s existing service management, monitoring, and security tooling, helping teams anticipate, detect, and resolve issues before they impact business operations. In the United Kingdom, the partnership has delivere
VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer18.5.2026 09:00:00 EEST | Press release
VahatiCor, Inc., a medtech company developing interventional therapies for Coronary Microvascular Dysfunction (CMD), announced today the appointment of Harry D. Rowland, Ph.D., as Chief Executive Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260517830314/en/ VahatiCor CEO, Harry D. Rowland, Ph.D. Rowland previously served as Chief Executive Officer and President of Endotronix, where he led the development and commercialization of the Cordella™ Pulmonary Artery Sensor and Heart Failure System. Under his leadership, Endotronix raised over $150 million and grew to more than 150 employees. He also oversaw the PROACTIVE-HF pivotal trial from execution through FDA premarket approval and commercial launch. Following its acquisition by Edwards Lifesciences in 2024, Rowland stayed on to support key CMS national coverage and CE Mark milestones. "Harry has led a medical company through this arc before. He took Endotronix from
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom